Questcor Pharmacueticals (QCOR) Tops Q1 EPS by 10c; Revs Heavy

Questcor Pharmacueticals (NASDAQ: QCOR) reported Q1 EPS of $0.61, $0.10 better than the analyst estimate of $0.51. Revenue for the quarter came in at $96 million versus the consensus estimate of $87.08 million.

For earnings history and earnings-related data on Questcor Pharmacueticals (QCOR) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Tencent Holdings (700:HK) (TCEHY) PT Lowered to HK$625 at Benchmark to Reflect Downward Earnings Revisions
• Cantor Fitzgerald Reiterates Overweight Rating on Global Net Lease (GNL)